Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 15, 2021, titled "ALKEM launches Brivaracetam in India under the brand name Brivasure for treatment of Epilepsy".
Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 15, 2021, titled "ALKEM launches Brivaracetam in India under the brand name Brivasure for treatment of Epilepsy".